ClinConnect ClinConnect Logo
Search / Trial NCT04016870

Project My Heart Your Heart: Pacemaker Reuse

Launched by UNIVERSITY OF MICHIGAN · Jul 8, 2019

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Life expectancy ≥ 2 years.
  • Indications for device implantation must be fulfilled per standard of care. Consistent with 2008 American College of Cardiology / American Heart Association guidelines for device therapy, one of the following class I indications must be met.
  • Sinus Node Dysfunction
  • Acquired Atrioventricular (AV) Block
  • Chronic Bifascicular Block
  • Hypersensitive Carotid Syndrome
  • Lack of financial ability to pay for a new device must be assessed and documented.
  • All other methods of new device acquisition must be exhausted.
  • Patient must be agreeable and able to follow-up with the implanting center within 2 weeks for wound check, at 2 months, 6 months, and every 6 months thereafter for routine pacemaker checks.
  • Exclusion Criteria:
  • Severe valvular disease
  • Severe pulmonary disease
  • End-stage renal disease (creatinine clearance \< 30 mL/min) whether or not on dialysis
  • Evidence of ongoing systemic infection
  • Prior pacemaker or implantable cardioverter-defibrillator implantation
  • Significant contraindication to pacemaker implantation per evaluation of the implanting physician (very high risk of complications).
  • Presence of any other condition that the local investigator feels would be problematic or would restrict or limit the participation of the patient for the entire study period
  • Pregnant women

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Eldoret, , Kenya

Freetown, , Sierra Leone

Barquisimeto, Lara, Venezuela

Ikeja, Lagos, Nigeria

Port Harcourt, Rivers, Nigeria

Asunción, , Paraguay

Monterrey, , Mexico

Maputo, , Mozambique

Patients applied

0 patients applied

Trial Officials

Thomas Crawford, MD

Principal Investigator

University of Michigan

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials